SGLT-2 inhibitors and cardiovascular outcomes in patients with and without a history of heart failure: a systematic review and meta-analysisVictor Razuk, Roxana Mehran, Mauro Chiarito et al.|European Heart Journal - Cardiovascular Pharmacotherapy|2022Cited by 41
Performance of the academic research consortium high-bleeding risk criteria in patients undergoing PCI for acute myocardial infarctionJohny Nicolas, Roxana Mehran, Mauro Chiarito et al.|Journal of Thrombosis and Thrombolysis|2021Cited by 20
Impact of target vessel choice on outcomes following percutaneous coronary intervention in patients with a prior coronary artery bypass graftFrans Beerkens, Annapoorna Kini, Ranbir Singh et al.|Catheterization and Cardiovascular Interventions|2021Cited by 5
IMPACT OF CORONARY ARTERY DISEASE ON CLINICAL OUTCOMES AFTER TAVR: INSIGHTS FROM THE BRAVO-3 RANDOMIZED TRIALDaniel Feldman, George Dangas, Davide Cao et al.|Journal of the American College of Cardiology|2022Cited by 2
Abstract 12805: Incidence and Predictors of Myocardial Infarction or Stent Thrombosis in High-Bleeding Risk Patients Undergoing Percutaneous Coronary InterventionJohny Nicolas, Roxana Mehran, Alessandro Spirito et al.|Circulation|2022Cited by 1